Sophie Laribiere

Sophie Laribiere currently serves as the VP and Head of Neurosciences in Global Regulatory Affairs at Ipsen since January 2024. Prior to this role, Sophie held the position of Senior Director for Global Regulatory Affairs Development Strategy at Alexion Pharmaceuticals, Inc., overseeing regulatory strategies for assets in various phases of development. Sophie's extensive experience in regulatory affairs includes significant roles at Eli Lilly and Company, where responsibilities spanned from Principal Regulatory Consultant focusing on EU and Emerging Markets to regulatory submissions for early phase products. Sophie’s career also includes positions at Merck Sharp & Dohme, Aventis, and GSK, where expertise in regulatory processes, clinical trials, and team management was developed. Academic qualifications include studies at Paris-Sud University and Université de Bordeaux.